An incredible first day at #ASMMicrobe in Atlanta connecting with clients, fellow professionals, and friends, sharing insights, and discussing the latest advancements in microbiology and diagnostics. If you're attending, let us know so we can meet face to face! #ASMMicrobe2024 #MedicalDevices #IVDs #InVitroDiagnostics #HealthcareInnovation
MDC Associates, Inc.’s Post
More Relevant Posts
-
Join the conversation!
Endpreeclampsia.org is hosting a virtual chat with Dr. Rebecca Khan and Dr. Champa Woodham to discuss the new biomarker blood test for preeclampsia risk assessment. Join the conversation live or on-demand to learn about the clinical study and FDA indication, implementation of a novel test, and real-world impact captured by Dr. Woodham in practice. Follow the link to register: https://lnkd.in/g4yRdDtX #thermofisheremp
To view or add a comment, sign in
-
-
▶️ Diagnostics play a vital role in the informed prescription of antibiotics 💊. ▶️ Established antimicrobial susceptibility tests (AST) serve as reliable tools to assess resistance to antibiotics through phenotypic determination [6] ▶️ There are several solutions to support the AST performance available in the market. In this white paper 📄, we examine the topic ‘How to perform real-time antimicrobial susceptibility testing (AST).’ Read to learn more about the current diagnostic workflow vs rapid AST diagnostic workflow. 👇 #sysmexnordic
To view or add a comment, sign in
-
📣 Upcoming event alert! Thermo Fisher Scientific is organizing a webinar 💻 about effective use of PCT (procalcitonin) to manage older and at-risk patients: 📅June 12th, 2024 🕓16:00 CET Join this initiative for an insightful panel discussion on the effective use of Thermo Scientific B·R·A·H·M·S PCT (invaluable marker that helps assess bacterial infections and aids in antibiotic therapy for aging and frail patients). Learn from top experts how B·R·A·H·M·S PCT supports responsible antibiotic use in older populations. 👨Gaetan Gavazzi 👨Thomas M. File Jr. 👨Michael Bauer This webinar will be moderated by Mike Broyles, PharmD, Director of Medical Affairs for Thermo Fisher Scientific Biomarkers. Don‘t miss out this opportunity! Register now to secure your spot: 🔗 https://bit.ly/3X9olry #EuGMS #PCT #GeriatricMedicine #HealthcareInnovation #ThermoFisherScientific #Webinar #Learning
To view or add a comment, sign in
-
-
What’s evolved in #AntimicrobialStewardship since the Jim O’Neill report of 2016? 💡 Find out at #ECCMID2024 with bioMérieux’s Integrated Symposium “Tackling drug-resistant infections globally with rapid diagnostics: Advancements in Microbiology since the Jim O’Neill report” ◾ Keynote: “Societal impact of AMR, with an update since the publication of the O’Neill Report” by Lord O’Neill of Gatley ◾ “Inappropriate empirical treatments in Blood Stream Infections: where we stand and how to improve?” by Prof. Romney Humphries ◾ “How Clinical Decision Support Systems and Dashboards can support Antimicrobial Stewardship”: by Prof. Céline Pulcini 📅 It’s on April 28th from 16-17:30 at HALL 6 ROOM L Find out more about bioMérieux's program at ECCMID: https://lnkd.in/degYpFD8 #ESCMIDGlobal #AntimicrobialStewardship #ECCMID2024 #WeArebioMérieux
To view or add a comment, sign in
-
Clinical laboratories performing antimicrobial susceptibility testing (AST) are now required to use breakpoints currently recognized by Clinical and Laboratory Standards Institute (CLSI) or the FDA. Together CLSI, APHL - Association of Public Health Laboratories, American Society for Microbiology, College of American Pathologists (CAP), and Centers for Disease Control and Prevention have jointly developed this Breakpoint Implementation Toolkit (BIT) to assist clinical laboratories in updating minimal inhibitory concentration (MIC) breakpoints. Get it here >> https://ow.ly/g63T50QNTnY.
To view or add a comment, sign in
-
-
About a month ago, we announced positive results from a randomized controlled clinical trial on suPAR-guided antibiotic treatment in sepsis at the European Shock Conference in Vienna. 💥 What is so revolutionary about the SUPERIOR study? 🤔 Some patients with only one qSOFA risk sign require early treatment to prevent progression, and the challenge is to find the ones that benefit from early treatment. The study shows that the measurement of suPAR in patients with one risk sign (1 point of qSOFA score) identifies a subgroup of patients at high risk of an unfavorable outcome and early deterioration if not treated. These patients receive significant benefits from early meropenem treatment, guided by suPARnostic®. So, by utilizing suPAR to direct sepsis treatment, hospitals can minimize antibiotic usage to those who will genuinely benefit from it, while also promptly initiating treatment to prevent the escalation to more critical stages of sepsis, leading to the potential for saving more lives! Visit our website: https://www.virogates.com/ #sepsis #antibiotics #suPAR
To view or add a comment, sign in
-
-
CEO/Investor at NXTPHASE AB, Co-founder/partner at Finserve Global Security Fund. Open for Interim manager assignments.
Hamlet BioPharma - I just love this company, their research and to be part of the journey by investing in the stock. Investing in research companies within the pharmaceutical industry often involves a high level of risk, and I usually am cautious about it. However, Hamlet BioPharma continues to deliver brilliant results and presents positive news almost every week. Check out the company and listen to the great MSQ webinar where Catharina Svanborg, founder and chairman of Hamlet BioPharma, presents the company and the studies. Keep up the good work Team Hamlet! Hamlet Bio Pharma can be found where stocks are traded… for example, Nordnet and Avanza. Disclaimet: As always…This is by no means a recomendation to invest and there are always risks involved by doing so. #hamletbiopharma #Nordnet #Avanza
Watch a webinar interview with Hamlet BioPharma´s founder and Chairman, Catharina Svanborg, hosted by MSQ ventures in the MSQ’s CEO Webinar series, released during the JP Morgan Health Care Conference 2024, this week. #cancerresearch #cancertreatment #bladdercancer #infections #immunotherapy #hamletbiopharma #jpm2024 #jpmorgan https://lnkd.in/dmQVCJgG
MSQ CEO Webinar Series with Hamlet BioPharma
https://www.youtube.com/
To view or add a comment, sign in
-
🎉 Exciting News Alert! 🎉 At dicentra, we are thrilled to be collaborating with the innovative minds at Doc Lab Inc. in revolutionizing the diagnostics space! 🌟 Together, we're embarking on a groundbreaking clinical utility study—the FIRST of its kind—aimed at accelerating diagnostic results for quicker diagnosis and treatment. 🚀 Our focus? Introducing faster, more accurate PCR tests for Urinary Tract Infections (UTIs). Traditionally, UTI diagnostics have been hindered by slow conventional tests, often resulting in broad antibiotic usage and the looming threat of antibiotic resistance. But with Doc Lab's cutting-edge PCR technology, results are not only lightning-fast but also boast heightened sensitivity and accuracy. 💡 This isn't just about innovation; it's about fostering better health outcomes for everyone. By swiftly identifying pathogens with precision, we're paving the way for more targeted treatments, reducing the risk of antibiotic resistance, and ultimately, improving patient care. Together, we're shaping the future of diagnostics, one breakthrough at a time. 💪 #HealthcareInnovation #BetterHealthOutcomes #DiagnosticsRevolution
To view or add a comment, sign in
-
What’s evolved in #AntimicrobialStewardship since the Jim O’Neill report of 2016? 💡 Find out at #ECCMID2024 with bioMérieux’s Integrated Symposium “Tackling drug-resistant infections globally with rapid diagnostics: Advancements in Microbiology since the Jim O’Neill report” ◾ Keynote: “Societal impact of AMR, with an update since the publication of the O’Neill Report” by Lord O’Neill of Gatley ◾ “Inappropriate empirical treatments in Blood Stream Infections: where we stand and how to improve?” by Prof. Romney Humphries ◾ “How Clinical Decision Support Systems and Dashboards can support Antimicrobial Stewardship”: by Prof. Céline Pulcini 📅 It’s on April 28th from 16-17:30 at HALL 6 ROOM L Find out more about bioMérieux's program at ECCMID: https://lnkd.in/epqaPYJ3 #ESCMIDGlobal #AntimicrobialStewardship #ECCMID2024 #BeAGameChanger
BOOTH HIGHLIGHTS
go.biomerieux.com
To view or add a comment, sign in
-
Manager at KCBraids & Beads - Designer/Maker of beaded and braided Jewellery/Gifts and Collectables - Fascinators and Cake Toppers - Custom Orders Welcome - #SBSwinner
Check out this information about Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia - a multi-centred randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial Https//:rdcu.be/dMeJq #BioDriveAFS
To view or add a comment, sign in
-